crossNN Is an Explainable Framework for Cross-Platform DNA Methylation-Based Classification of Tumors

crossNN is an explainable framework for cross-platform DNA methylation-based classification of tumors

DNA methylation-based classification of (brain) tumors has emerged as a powerful and indispensable diagnostic technique. Initial implementations used methylation microarrays for data generation, while most current classifiers rely on a fixed methylation feature space. This makes them incompatible with other platforms, especially different flavors of DNA sequencing. Here, we describe crossNN, a neural network-based machine learning framework that…

Tumor diagnostics: AI model detects more than 170 types of cancer

The MRI shows a brain tumor in an inauspicious location, and a brain biopsy will entail high risks for a patient who had consulted doctors due to double vision. Situations such as this case prompted researchers at Charité—Universitätsmedizin Berlin to look for new diagnostic procedures. The result is an AI model.

PlexusDx Releases Genetic Methylation Test and MTHFR Testing Kit on Amazon - Journal of Cyber Policy

At-home Genetic Methylation Test Kit and MTHFR Testing Kit by PlexusDx. Includes 95+ DNA reports analyzing key genes like MTHFR, COMT, BHMT, AHCY, and folate metabolism. Offers personalized supplement and meal plan recommendations. Industry-leading DNA test analyzes 95+ genetic markers for methylation, MTHFR, and detox pathways—now available for fast, convenient purchase on Amazon. ALPHARETTA, GA, UNITED STATES, June 6, 2025 /EINPresswire.com/ —…

AI Model Identifies Over 170 Cancer Types, Revolutionizing Tumor

In a groundbreaking advancement poised to revolutionize cancer diagnostics, researchers at Charité – Universitätsmedizin Berlin, in collaboration with international partners, have unveiled an artificial intelligence (AI) model capable of precisely classifying tumors based on their epigenetic signatures. Published in the renowned journal Nature Cancer, this novel AI framework, named crossNN, promises to transform the way oncologists diagnose and …